Neutral impactOrders & Deals
Motilal Oswal sees Aster DM EBITDA rising 25% CAGR through FY28; sets Rs 910 target
Economic Times 1 hr ago·29 Sept 2026, 7:10 am
Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and Rs 910 target, citing merger synergies, capacity expansion and improving operating metrics. The brokerage expects revenue, EBITDA and PAT to grow at CAGRs of 19.5%, 25% and 33%, respectively, through FY28.
Affected stocks
Neutral1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Aster DM Quality Care (ASTERDM).
- Category: Orders & Deals.
Why it matters
A routine update for Aster DM Quality Care. Use the price and stock snapshot to gauge how the market is responding.
